hotspot -WSS

hotspot

author：knowledge 2025-09-28 01:34:38 - browse：856

Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022 — Photo illustration: STAT; Photo: Adobe

Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

“Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

Wikipedia

WSS

Medicare Advantage 2025 payments will dip, Biden administration says

People with mental disorders often marry others with same

More tobacco lobbyists active in statehouses

Bird flu outbreak in cows is latest avian flu curveball

Exact Sciences stock tumbles despite strong cancer detection sales

Why does health care cost so much? A reading guide

focus

hotspot

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Dogs on Prozac: What pet anti

Walensky prepares to leave CDC — and Congress — behind

FTC falls short on scrutinizing hospital mergers, study says

At least 13 dead in Texas as scorching temps continue

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

United colonoscopy coverage change 'may cost lives,' doctors say

Mass General Brigham physicians react to latest merger step

What does generative AI mean for health care? We asked experts

Element Biosciences CEO lays out genome sequencing strategy

focus

Health care needs a new profession: neuroimaging counseling

Why rehabilitation engineers need to center patients in their research

Scientific mystery highlights the blind spots in genomics databases

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

FTC falls short on scrutinizing hospital mergers, study says

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

entertainment

focus

Wikipedia

leisure time